| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
|
| | 3'-azido-2',3'-dideoxy-5-methylcytidine Basic information |
| Product Name: | 3'-azido-2',3'-dideoxy-5-methylcytidine | | Synonyms: | 3'-azido-2',3'-dideoxy-5-methylcytidine;3'-Azido-2',3'-dideoxy-4-deoxo-4-imino-5-methyluridine;CS-92;AzddMeC;Az-Dcme;Azidodideoxymethylcytidine;3’-Azido-2’,3’-dideoxy-5-methyl cytidine, AzddMC | | CAS: | 87190-79-2 | | MF: | C10H14N6O3 | | MW: | 266.26 | | EINECS: | | | Product Categories: | | | Mol File: | 87190-79-2.mol |  |
| | 3'-azido-2',3'-dideoxy-5-methylcytidine Chemical Properties |
| storage temp. | 4°C, away from moisture | | solubility | DMSO : 200 mg/mL (751.15 mM; Need ultrasonic) | | form | Solid | | pka | 14.438±0.10(predicted) | | color | White to off-white |
| | 3'-azido-2',3'-dideoxy-5-methylcytidine Usage And Synthesis |
| Uses | AzddMeC is used as an antiviral agent for treating viral infection. | | in vivo | The pharmacokinetics of AzddMeC are characterized following intravenous and oral administration of 60 mg/kg of the compound to male rhesus monkeys. 3'-azido-3'-deoxythymidine (AZT) is a major metabolite of AzddMeC in monkeys. AzddMeC concentrations in serum declined rapidly in a biexponential fashion with the terminal half-life ranging from 0.5 to 1.3 hr. Renal excretion of unchanged nucleoside and metabolic deamination yielding AZT are the primary routes of AzddMeC clearance. The oral bioavailability is 26%[2]. | | IC 50 | HIV-2; HIV-1: 9 nM (EC50, Human PBM cells); HIV-1: 6 nM (EC50, Human macrophages) |
| | 3'-azido-2',3'-dideoxy-5-methylcytidine Preparation Products And Raw materials |
|